13EGP
- Active ingredient
- naftidrofuryl
- Strength
- 200 mg
- Form
- tablet
- Manufacturer
- el-obour > repharma pharmaceuticals
- Route
- oral.solid
Uses
Used for symptomatic treatment of peripheral vascular disease and intermittent claudication.
Do not use if
Contraindicated in hypersensitivity and a history of recurrent calcium oxalate kidney stones.
Side effects
May cause nausea, abdominal discomfort, diarrhea, and rash.
Warnings
Adequate hydration is recommended during treatment.
How it works
Acts mainly as a serotonin receptor antagonist and improves tissue oxygen utilization.
Storage
Store at room temperature away from moisture.